Viridian Therapeutics, Inc.DE
VRDN—
Viridian Therapeutics, Inc.DEVRDN$0.00
+$0.00(+NaN%)Past Year
Jun 25Sep 25Dec 25Mar 26Jun 26
Key statistics
Market cap
—
P/E ratio
—
EPS (diluted)
$-5.31
Dividend yield
0.00%
Dividend / share
$0.00
Revenue
$70.85M
Net income
$-342.60M
Net margin
-483.6%
Gross margin
—
Dividends & financials
Viridian Therapeutics, Inc.DE (VRDN) reported revenue of $70.85M and net income of $-342.60M, or $-5.31 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.